期刊文献+

卡维地洛对多柔比星诱导心肌病大鼠氧化应激的影响

Influence of carvedilol on oxidative stress in rat with adriamycin-induced cardiomyopathy
下载PDF
导出
摘要 目的:探讨卡维地洛(carvedilol,CVD)对多柔比星(adriamycin,ADR)致心肌病大鼠氧化应激水平的影响及其可能机制。方法:采用腹腔注射多柔比星建立心肌病大鼠模型,随机分为卡维地洛组和多柔比星组,每组10只。另取正常大鼠10只为正常对照组。卡维地洛组每日给予卡维地洛60 mg/kg;多柔比星组、正常对照组每日给予相同体积生理盐水,观察8周。第9周行心脏超声和血流动力学检测,测定心室胶原含量,总抗氧化能力和丙二醛浓度。结果:卡维地洛组与多柔比星组相比,可显著提高左室射血分数(P<0.01);降低心肌胶原容积分数(P<0.01)。与正常对照组相比,多柔比星组总抗氧化能力显著降低(P<0.01),丙二醛浓度显著升高(P<0.01);而与多柔比星组相比,卡维地洛组可显著提升总抗氧化能力(P<0.01),明显降低丙二醛浓度(P<0.05)。结论:卡维地洛能显著改善多柔比星引起的血流动力异常,改善心脏收缩与舒张功能,逆转心肌重塑,可能与其提高心肌抗氧化应激能力有关。 Objective: To investigate the influence of oxygen stress in rat with adriamycin-induced cardiomyopathy, and to intervene with the third-generation blocker: carvedilol to explore its possible mechanism. Methods: Male Sprague-Dawley rats were administered adriamycin intraperitoneally injected. Randomly divided into two groups ( n = 10 in each group) : carvedilol group ( 60 mg/kg daily), adriamycin group and another normal heart control group(giving an equivalent volume of 0.9% saline daily). After 8 weeks of remedy, echocardiography, hemodynamic parameters, the volumetric fraction of collagenous fibre (CVF) and oxidative stress including total antioxidation capacity(T-AOC) and malondialdehyde (MDA) were studied. Results: Compared with adriamycin group, carvedilol group can significantly improve left ventricular ejection fraction( P 〈 0.01 ) and depress CVF obviously ( P 〈 0.01 ). Compared with control group, adriamycin group can significantly decrease the activity of T-AOC( P 〈 0.01 ) and improve the contents of MDA greatly(P 〈0.01 ). The activity of T-AOC in the carvedilol group was enhanced significantly compared with that in the adriamycin group(P 〈0.01 ). The contents of MDA in the carvedilol group were decreased compared with that in the adriamycin group( P 〈0.05 ). Conclusion: Carvedilol can relieve adriamycin-induced hemodynamic abnormality evidently, improve cardiac systolic and diastolic function greatly and reverse ventricular remodeling. This mechanism may be concerned with its improvement to oxygen stress.
出处 《江苏大学学报(医学版)》 CAS 2008年第4期318-321,I0002,共5页 Journal of Jiangsu University:Medicine Edition
基金 江苏省人事厅"六大人才峰会"基金资助项目(06-B-014)
关键词 多柔比星 卡维地洛 氧化应激 adriamycin carvedilol oxidative stress
  • 相关文献

参考文献10

  • 1Quiles J, Huertas JR, Battino M, et al. Antioxdant nutrients and adriamycin toxicity[J]. Toxicology, 2002, 180(1): 79-95.
  • 2Packer M, FowlerMB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival(COPERNICUS) study[J]. Circulation, 2002, 106(17): 2194-2199.
  • 3Romeo F, Li D, Shi M, et al. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway[J]. Cardiovasc Res, 2000, 45(3): 788-794.
  • 4Wang R, Miura T,Harada N,et al. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes[J]. J Pharmacol Exp Ther,2006, 318(1): 45-52.
  • 5白洁,陈蓉,盛佳,汪健飞,张国辉.SD大鼠扩张型心肌病模型的建立[J].江苏大学学报(医学版),2006,16(3):210-212. 被引量:14
  • 6吴强,李隆贵,蔡运昌,杨天和,王晓峰,耿召华.不同剂量卡维地洛对心衰大鼠心肌氧化应激和细胞凋亡的影响[J].心脏杂志,2003,15(5):410-413. 被引量:6
  • 7Reeve JL,Szegezdi E,Logue SE, et al. Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL[J]. J Cell Mol Med, 2007, 11(3): 509-520.
  • 8L′Ecuyer T, Sanjeev S, Thomas R, et al. DNA damage is an early event in doxorubicin-induced cardiac myocyte death[J]. Am J Physiol Heart Circ Physiol, 2006, 291(1): H1273-H1280.
  • 9Mercuro G, Cadeddu C, Piras A, et al. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers [J]. Oncologist, 2007, 12(9): 1124-1133.
  • 10Lien YC, Lin SM, Nithipongvanitch R, et al. Tumor necrosis factor receptor deficiency exacerbated adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection [J]. Mol Cancer Ther, 2006, 5(2): 261-269.

二级参考文献16

  • 1白融,吕加高,卜军,周强,刘念,阮燕菲,王晨,罗惠珍,王琳.快速心室起搏制备扩张型心肌病心力衰竭犬模型的方法学探讨[J].中国实验动物学报,2004,12(3):159-162. 被引量:10
  • 2李双杰,张召才,陈瑞珍,杨英珍,陈灏珠,葛均波.Balb/c小鼠CVB_3病毒性扩张型心肌病并心力衰竭模型的建立[J].复旦学报(医学版),2004,31(6):559-561. 被引量:10
  • 3Givertz MM, Sawyer DB, Colicci WS, et al. Antioxidants and myocardial contractility illuminating the "dark side " of β-adrenergic receptor activation[J]. Circulation, 2001, 103(6): 782-783.
  • 4Sawyer DB, Colieei WS. Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited[J]. Circ. Res, 2000, 86(2) :119-120.
  • 5Cesselli D, Jakoniuk I, Barlucchi L, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy[J]. Circ Res, 2001, 89(3): 198-200.
  • 6Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decrease cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion[J]. Circulation, 1999, 99(13): 1685-1691.
  • 7Eichhorn E J, Bristow MR. The carvedilol prospective randomized cumulative survival (COPERNICUS) trial[J]. Curt Control Trials Cardiovasc Med, 2001, 2(1) : 20-23.
  • 8Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial[J]. Lancet, 2001, 357(9266):1385- 1390.
  • 9Abreu RM, Santos DJ, Moreno A J, et al. Effects of Carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress[J], J Pharmacol Exp Ther, 2000, 295(3):1022-1030.
  • 10Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies[J].Circulation,1996,93(5):841 -842.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部